AMD Associazione Medici Diabetologi

What AMD Associazione Medici Diabetologi does

AMD – Associazione Medici Diabetologi is an Italian non-profit professional medical association founded in 1974, headquartered in Rome, and governed by a national board of elected diabetologists. It represents diabetologists across Italy through 21 regional sections and serves as the principal scientific and educational society in the field, publishing the peer-reviewed journals Acta Diabetologica (with Springer) and JAMD, issuing the Standard di Cura clinical guidelines, hosting the Algoritmi AMD therapeutic decision tools, and running an ECM-accredited continuing medical education portfolio that includes national congresses, regional meetings, distance learning (FAD), and an AMD mobile app. Its foundational technology assets are the Cartella Clinica Diabetologica Informatizzata (CCDI) electronic clinical records system deployed across regional centers and the Annali AMD annual reports/database, which aggregate real-world quality-of-care indicators from hundreds of Italian diabetes centers. The association operates a wholly-owned research foundation (Fondazione AMD ETS, registered with the national research register since April 2011) and a benefit company subsidiary (AMD Srl SB) for events and professional services; it partners with SID, AIOM, OSDI, Politecnico di Milano, SDA Bocconi, and patient associations such as Diabete Italia.

The association's revenue is not publicly disclosed; income sources implied by the offering mix include individual membership dues, ECM-accredited course and event fees, journal/advertising revenue, corporate sponsorship of educational activities, research grants flowing through Fondazione AMD ETS, and the Italian 5x1000 tax-deductible donation program. The operating model is essentially a federated non-profit: the national staff of approximately 25 employees coordinates with elected regional presidents who run local sections and clinical-leadership activities. Distribution is exclusively Italy-focused through the regional section network, with no claimed international footprint beyond the Springer-published Acta Diabetologica and English-language AMD Digital Network platform.

Name

AMD Associazione Medici Diabetologi

Legal name

Associazione Medici Diabetologi (AMD)

Website

https://aemmedi.it

Company type

Private

Operating status

Operating

Short description

AMD Associazione Medici Diabetologi is the national Italian professional society for diabetologists, founded in 1974, operating 21 regional sections and publishing clinical guidelines, peer-reviewed journals, and the Annali AMD real-world care database for Italian diabetes specialists.

Ownership category

akta.pro rank

Product category

Professional Medical Association - Diabetology

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAKADAA

Diabetes (General)

Healthcare & Life Sciences/Specialist Medical Practice/Endocrinology & Diabetes

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

SECONDARYHLAJANAG

Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer)

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Program Evaluation & Surveillance

SECONDARYHLAHAHAJ

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

Keywords

• Professional medical association
• Diabetes clinical guidelines
• Continuing medical education
• Clinical research database
• Peer-reviewed scientific journals

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels6 records

Core offering

AMD – Associazione Medici Diabetologi is a non-profit professional medical association for Italian diabetologists, offering scientific publications (JAMD, Acta Diabetologica), annual clinical quality reports (Annali AMD), national clinical standards and therapeutic algorithms, ECM-accredited continuing medical education (FAD programs), professional networking through 21 regional sections, and research infrastructure via its wholly-owned Fondazione AMD ETS. It functions as the reference scientific society for Italian diabetology, providing clinical guidelines, data collection systems, and collaborative research programs.

Product overview

AMD – Associazione Medici Diabetologi is a professional medical association for diabetologists in Italy, not a product company. The association provides scientific publications (JAMD journal, Acta Diabetologica, Annali AMD annual reports), clinical guidelines (Standard di Cura), distance learning programs (FAD), mobile apps, digital health initiatives, and operates through its research foundation (Fondazione AMD). These are membership services and professional resources, not commercial products.

Differentiator

Problem solved

Functional benefit

Brands

• Annali AMD: Annual reports and publications on diabetes care quality indicators in Italy
• Fondazione AMD
• AMDcomunicAzione
• AMD Giovani
• Scuola formazione AMD

Products and services

• Annali AMD Annual reports and monographs documenting diabetes care quality indicators and outcomes data across Italian diabetes centers. For physicians, researchers, and healthcare institutions interested in diabetes care benchmarking.
• JAMD (The Journal of AMD) Peer-reviewed scientific journal published by AMD covering diabetology research. For researchers, clinicians, and academic audiences in diabetes care.
• Acta Diabetologica International peer-reviewed journal covering diabetes research, published by AMD in partnership with Springer. For international research and clinical audiences.
• Standard di Cura AMD National clinical care standards and therapeutic algorithms for diabetes management, published by AMD as the authoritative reference for Italian diabetology practice. For diabetologists, endocrinologists, and diabetes care teams.
• FAD AMD (Formazione a Distanza) Distance learning and continuing medical education (ECM) programs for diabetologists, providing accredited training remotely. For practicing diabetologists and endocrinologists needing continuing education credits.
• App AMD Mobile applications developed by AMD providing digital tools and resources for diabetes management support. For diabetologists and diabetes care professionals.
• Biblioteca AMD Digital library and research resources for diabetologists providing centralized access to clinical references and educational materials. For AMD members and diabetology practitioners.
• Fondazione AMD The AMD Foundation (Fondazione AMD ETS), a wholly-owned research entity promoting scientific research in diabetes and metabolic diseases. Supports clinical studies, scholarships, and training programs. For researchers, institutions, and donors supporting diabetes research.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Universities and Research InstitutionscoreStrategic or Co-development PartnerFondazione AMD operates in collaboration with universities, public and private health structures, research institutions, and foundations to promote scientific research in diabetes and metabolic diseases.
• SID - Società Italiana di DiabetologiacoreStrategic or Co-development PartnerJoint congresses and educational events organized at national and regional levels. Collaborative development of clinical guidelines and standards of care.
• AMD-AIOM-SID-SIE-SIF (Inter-society group)coreStrategic or Co-development PartnerInter-society working group focused on diabetes and cancer research, combining expertise from multiple Italian medical societies.
• AMD-OSDI (Terapia Iniettiva)minorStrategic or Co-development PartnerInter-society group dedicated to injectable therapy in diabetes, developing guidelines and educational programs.
• Politecnico di MilanocoreStrategic or Co-development PartnerCollaboration on Digital and Future Health executive training program. Joint project on Digital Twin technology received recognition/mention.
• SDA BocconiminorStrategic or Co-development PartnerPartnership for MIND-AMD (Managing Innovation In Diabetes) executive education program in performance measurement and management.
• LIUC Business SchoolminorStrategic or Co-development PartnerCollaboration on GOLD Project for management and procurement training in diabetology.
• Infomedica S.r.l.minorOthersExternal company responsible for website management and technical services for aemmedi.it.
• Patient AssociationscoreStrategic or Co-development PartnerCollaboration with patient associations including Diabete Italia and Diabete No Grazie for public health campaigns and patient education initiatives.
• Corriere della Sera Forum DiabeteminorGTM or Marketing PartnerCollaborative forum on diabetes hosted by Corriere della Sera newspaper for public education and awareness.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• SID - Società Italiana di Diabetologia: Italian scientific society for diabetology directly competing/collaborating with AMD on the same diabetologist audience. Joint congresses and shared inter-society groups (e.g., diabetic foot, technology) make it a direct functional peer in Italian diabetes knowledge leadership.
• OSDI - Operatori Sanitari di Diabetologia Italiani: Italian association for non-physician diabetes healthcare operators (nurses, dietitians, podiatrists). AMD's diabetes care team segment overlaps directly with OSDI's membership, and the two collaborate on the AMD-OSDI injectable therapy work group.
• SIE - Società Italiana di Endocrinologia: Italian society for endocrinology covering the broader specialty that includes diabetology. Many Italian diabetologists hold dual SIE/AMD membership, and the two societies co-lead the intersociety diabetes-and-cancer group, making SIE a closely overlapping domestic peer.

Others

• AMD-AIOM-SID-SIE-SIF Diabete e Tumori: Inter-society working group AMD co-leads with oncology (AIOM), endocrinology (SIE), and pharmacology (SIF) societies. It is a multi-society peer initiative where AMD plays a convening role analogous to a specialty consortium.
• Diabete Italia: Italian patient-advocacy federation for diabetes representing people with diabetes. Listed as AMD's core patient-association partner, and represents the demand-side counterpart to AMD's clinician-side mission, useful as a comparable for stakeholder engagement models.

Broad incumbents

• EASD - European Association for the Study of Diabetes: Largest European diabetes research society, publishes Diabetologia and runs the EASD Annual Meeting. EASD is a broader incumbent whose pan-European congress, guidelines, and grants compete with AMD's role for Italian diabetologists seeking international visibility.
• ADA - American Diabetes Association: Global diabetes professional and research organization publishing Diabetes Care and Diabetes. As international standards of care origin and a major CME provider, ADA is the global benchmark against which AMD positions its Italian 'Standard di Cura' and algorithms.
• IDF - International Diabetes Federation: Global umbrella for diabetes associations producing the IDF Diabetes Atlas and global guidelines. Relevant comparable because AMD plays a similar national-convener role in Italy that IDF plays globally, and IDF Italian member activities often overlap with AMD's public health agenda.

Regional players

• AGD Italia - Associazione per l'aiuto ai giovani diabetici: Italian association supporting children and young adults with Type 1 diabetes and their families. Comparable as a domestic diabetes-focused community organization with overlapping topics (T1D transition, education) and direct partnership touchpoints with AMD.
• JDRF Italia: Italian chapter of JDRF (now Breakthrough T1D), the leading global funder of Type 1 diabetes research. Comparable as a disease-focused nonprofit that channels research funding and patient advocacy in the same T1D space AMD addresses through its Type 1 and transition group.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles26 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMD Associazione Medici Diabetologi